Strategic Collaboration | Sanyou Bio and NovoCodex Partner to Co-Develop Innovative Dual-Payload ADCs
SHANGHAI and SHAOXING, China, Sept. 24, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd. ('Sanyou Bio') and NovoCodex Biopharmaceuticals Co., Ltd. ('NovoCodex') jointly announced that the two companies have formally entered into a strategic collaboration agreement. The partnership will focus on the joint development of innovative antibody-drug conjugates (ADCs), leveraging Sanyou Bio's strengths in innovative ADC discovery powered by its AI-Super trillion antibody/molecule libraries (AI-...